Federica Matteucci

Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours

Stefano Severi, Oriana Nanni, Lisa Bodei et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 143 citations · Full text

Positron Emission Tomography, Oncologic Imaging, Medicine +8

177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study

Giovanni Paganelli, Maddalena Sansovini, A. Ambrosetti et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 121 citations

Endocrine Oncology, Gastrointestinal Oncology, Medicine +11

Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone

Ugo De Giorgi, Paola Caroli, Salvatore Luca Burgio et al. · Oncotarget · 2014 · 95 citations · Full text

18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide

Ugo De Giorgi, Paola Caroli, Emanuela Scarpi et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 93 citations

Urology, Oncologic Imaging, Medicine +8

68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients

Paola Caroli, Israel Sandler, Federica Matteucci et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 92 citations · Full text

Urology, Genitourinary Cancer, Medicine +6